Olpen 5 mg

Description

Olpen 5 mg is an ANVIS tablet product containing olanzapine 5 mg. The photographed carton holds three strips of ten tablets, giving 30 tablets per box. This entry records the labelled presentation and highlights the need for clinical supervision and monitoring.

Olpen 5 mg product specification

• Product name: Olpen
• Active ingredient: Olanzapine
• Labelled strength: 5 mg
• Dosage form: Tablets
• Pack presentation: 3 strips × 10 tablets
• Total quantity: 30 tablets
• Brand: ANVIS

Confirm the complete name and 5 mg strength before use. Other Olpen strengths need separate identification. The pack quantity describes the contents of the box. It does not determine a daily dose, and the number of tablets should not be used to estimate a treatment plan.

General information about olanzapine

Olanzapine is a prescription antipsychotic medicine used to help manage conditions such as schizophrenia and bipolar disorder. It can help with symptoms, but it does not cure the underlying condition. Some effects may take days or weeks to develop. Treatment decisions belong with the prescribing clinician.

Olpen 5 mg: precautions and monitoring

Continue treatment as prescribed and discuss changes with your doctor. Olanzapine can cause sleepiness, dizziness, constipation, increased appetite and weight gain. Do not drive or use machinery if sleepy. Alcohol can worsen drowsiness and unsteadiness.

Your clinician may monitor weight, blood sugar and cholesterol during treatment. Report new involuntary movements or troublesome side effects. Seek urgent medical help for difficulty breathing, signs of a stroke, or fever with muscle stiffness and sweating. Read the full leaflet for additional warnings.

Documentation and product enquiries

The NHS olanzapine overview and side-effect guide provide general ingredient information. For the complete Olpen 5 mg specification, contact ANVIS with the product name and strength. You can also browse our tablet catalogue.